Page last updated: 2024-08-16

ribavirin and Neutropenia

ribavirin has been researched along with Neutropenia in 73 studies

Research

Studies (73)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.37)18.7374
1990's1 (1.37)18.2507
2000's37 (50.68)29.6817
2010's34 (46.58)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iqbal, S; Raza, A; Yousaf, MI; Yousuf, MH1
Fazylov, VC; Guryanova, SV; Manapova, ER1
Hindi, NN; Saleh, MI1
Casado, JL; Dronda, F; Hermida, JM; Moreno, A; Moreno, S; Navas, E; Pérez-Elías, MJ; Quereda, C; Royuela, A; Serrano-Villar, S1
Abbas, SM; El-Feky, HM; Hegab, MF; Lashin, AH; Metwally, MA; Shaheen, YA1
Cao, ZH; Chen, XY; Du, XF; Guo, DD; Liu, YL; Lu, JF; Ma, LN; Zhang, YH1
Backus, LI; Belperio, PS; Cheung, R; Mole, LA; Shahoumian, TA1
Anagnostou, O; Andreadis, I; Deutsch, M; Kalafateli, M; Ketikoglou, I; Manolakopoulos, S; Mela, M; Papatheodoridis, G; Pectasides, D; Schini, M; Striki, A; Triantos, C1
Andriulli, A; Cozzolongo, R; Fontana, R; Iacobellis, A; Ippolito, A; Minerva, N; Niro, GA; Palmieri, O; Valvano, MR1
Angeli, E; Caputo, A; Cattelan, AM; Iannacone, C; Maida, I; Nasta, P; Pontali, E; Puoti, M; Verucchi, G1
Beumont-Mauviel, M; De La Rosa, G; Forns, X; Fried, MW; Fu, M; Jacobson, IM; Jessner, W; Kalmeijer, R; Lenz, O; Manns, MP; Ouwerkerk-Mahadevan, S; Peeters, M; Poordad, F; Scott, JA; Sinha, R; Zeuzem, S1
Gattei, V; Mauro, E; Mazzaro, C1
Ahn, SB; Choe, WH; Chung, JI; Jun, DW; Jung, KS; Kim, DY; Kim, JK; Kim, SG; Kim, W; Lee, SH; Park, SY; Seo, YS; Shim, JJ; Shin, HP1
Kim, HJ; Lee, HW; Lee, YJ; Park, SJ; Yang, SY; Yoo, KY1
Besheer, M; El-Karaksy, HM; El-Raziky, MS; Mogahed, EA; Mubarak, S; Saleh, D1
Banhegyi, D; Bergin, C; Chernova, O; DeMasi, R; Doroana, M; Gori, A; Hadacek, B; Liu, C; Nelson, M; Rockstroh, JK; Verucchi, G1
Ahlers, S; Bakalos, G; Coppola, C; Derbala, M; Ferenci, P; Foster, GR; Hassanein, T; Orlandini, A; Reddy, KR; Shiffman, ML; Tallarico, L1
Berden, FA; Blokzijl, H; de Knegt, RJ; den Hollander, J; Drenth, JP; Friederich, P; Kievit, W; Kuiken, SD; van Erpecum, KJ; van Hoek, B; van Nieuwkerk, CM; van Vonderen, MG; Willemse, SB1
Chan, A; Everson, GT; Fried, MW; Ghalib, R; Godofsky, E; Harrison, S; Hill, G; Najera, I; Nelson, D; Nyberg, L; Pockros, PJ; Rodriguez-Torres, M; Shiffman, ML1
Kristian, P; Pellová, A; Porubcin, S; Schréter, I1
Ferenci, P1
Chen, SC; Chuang, WL; Dai, CY; Hou, NJ; Hsieh, MY; Huang, JF; Lin, ZY; Wang, LY; Yang, JF; Yu, ML1
Ben-Ari, Z; Braun, M; Cohen, M; Cohen-Ezra, O; Katz, L; Manhaim, V; Rotman, Y; Tur-Kaspa, R1
Higaki, K; Ide, T; Karashima, T; Maeyama, Y; Narita, K; Okamura, S; Sakai, T; Sata, M; Sumie, H; Yoshikai, H1
Archimandritis, A; Elefsiniotis, J; Koskinas, J; Kostopoulos, P; Kotsiou, S; Kountouras, D; Savvas, S; Schina, M; Sidiropoulos, J; Zacharakis, G1
Celiento, M; De Rosa, A; Ripa, C; Schiano, A; Tambaro, O; Tarantino, L1
Alba, LM; Bulchandani, D; Nachnani, JS; Pandya, PK; Rao, GA1
Poll, R1
Alvarez-Uria, G; Day, JN; Nasir, AJ; Russell, SK; Vilar, FJ1
Mac Nicholas, R; Norris, S1
Cheong, HR; Cho, M; Heo, J; Kang, DH; Kim, DU; Kim, GH; Song, GA; Woo, HY; Yoon, KT1
Bakulin, IG; Sharabanov, AS1
de Knegt, RJ; Hansen, BE; Janssen, HL; Roomer, R1
Balistreri, WF; Barton, BA; Gonzalez-Peralta, RP; Goodman, Z; Haber, BA; Jonas, MM; Lobritto, SJ; Mohan, P; Molleston, JP; Murray, KF; Narkewicz, MR; Robuck, PR; Rosenthal, P; Rossi, S; Schwarz, KB; Smith, L; Valsamakis, A1
Hegarty, JE; Norris, S; O'Farrelly, C; Ryan, EJ; Tajuddin, T1
Doucette, K; Dryden, DM; Durec, T; Fassbender, K; Tandon, P; Vandermeer, B1
Afdhal, NH; Albrecht, JK; Brass, CA; Clark, PJ; Esteban, R; Fellay, J; Galler, GW; Ge, D; Goldstein, DB; Jacobson, IM; King, JW; Kwo, PY; Lawitz, EJ; McCone, J; McHutchison, JG; Muir, AJ; Naggie, S; Noviello, S; Patel, K; Pedicone, LD; Poordad, F; Shianna, KV; Shiffman, ML; Singh, A; Sulkowski, MS; Thompson, AJ; Tillmann, HL; Urban, TJ; Zhu, M; Zhu, Q1
Kang, P; Sun, LJ; Yan, BZ; Yu, JW; Zhao, YH2
Battyáni, Z; Hunyady, B; Kovács, B1
Beem, LW; Morse, ML1
Fazio, V; Giannini, EG; Marenco, S; Picciotto, A; Pieri, G; Savarino, V1
Berak, H; Dusheiko, GM; Ferenci, P; Gane, EJ; Hadziyannis, SJ; Han, KH; Harley, HA; Horsmans, YJ; Husa, P; Jenny Heathcote, E; Lee, SS; Messinger, D; Roberts, SK; Tatsch, F1
Gournay, J; Richou, C1
Doo, E; Everhart, JE; Ghany, MG; Heller, T; Hoofnagle, JH; Liang, TJ; Park, Y; Promrat, K; Soza, A1
Afdhal, NH1
Antonini, MG; Babudieri, S; Baiguera, C; Carosi, G; Fenu, L; Maida, I; Mura, MS; Puoti, M; Putzolu, V; Rezza, G; Rossi, S; Sassu, S; Viale, P; Zanini, B1
Ong, JP; Younossi, ZM1
Gonzalez, SA; Jacobson, IM1
Collantes, R; Gujral, H; Viscomi, C1
Kowdley, KV1
Collantes, RS; Younossi, ZM1
Assor, P; Bacq, Y; d'Alteroche, L; Gaudy, C; Lefrou, L; Senecal, D1
Afdhal, NH; Curry, MP1
Casillas-Davila, L; Chirino-Sprung, R; Dehesa-Violante, M; Díaz-Hernandez, M; Juarez-Navarro, A; Navarro, JM; Vera-de-León, L1
Sulkowski, MS1
Broissand, C; Fontaine, H; Lebray, P; Nalpas, B; Pol, S; Serpaggi, J; Sobesky, R; Vallet-Pichard, A1
Becker, MC; Bresson-Hadni, S; Bronowicki, JP; Di Martino, V; Lunel-Fabiani, F; Miguet, JP; Thevenot, T; Vanlemmens, C1
Franke, G; Lange, T; Niederwieser, D1
Deschênes, M; Hilzenrat, N; Nudo, CG; Wong, P1
Dar Santos, AE; Ford, JA; Partovi, N; Yoshida, EM1
Arora, S; Gish, RG; Murphy, B; Nelson, DR; O'Brien, C; Rajender Reddy, K; Xu, Y1
Bacon, BR; Barange, K; Harley, H; Lin, A; Nelson, D; Shafran, SD; Shiffman, ML; Solá, R; Soman, A; Suter, F; Zeuzem, S1
Bolokadze, N; Gochitashvili, N; Sharvadze, L; Tophuria, A; Tsertsvadze, T1
Adamski, A; Blessman, D; Gandotra, SD; Htwe, TH; Khardori, NM; Koirala, J; Mushtaq, A; Rao, S; Sangwan, G1
Llopis González, A; Márquez Peiró, JF; Morales Suárez-Varela, M; Pérez Peiró, C; Valero Alcocer, VE1
Manfredi, R; Sabbatani, S1
Esposito, S; Hamzeh, FM; Rustgi, VK; Shiffman, ML1
Bai, C; Collantes, R; Fang, Y; Farmer, D; Gujral, H; Gurung, C; Nader, FH; Ong, JP; Ramsey, L; Sjogren, M; Sjogren, R; Srishord, M; Terra, K; Younossi, ZM1
Arizcorreta-Yarza, A; Collado, A; Fernández-Fuertes, E; Girón-González, JA; González-Serrano, M; López-Cortés, LF; Lozano, F; Macías, J; Merino, D; Mira, JA; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Torres-Tortoso, M; Valera-Bestard, B1
Antonini, MG; Babudieri, S; Baiguera, C; Carosi, G; Dettori, G; Fenu, L; Maida, I; Manno, D; Mura, MS; Puoti, M; Zanini, B1
Anaissie, E; Aslan, T; Barlogie, B; Desikan, R; Fassas, AB; Mehta, J; Munshi, N; Siegel, D; Singhal, S1
Bishop, J; Coates, A; Fox, R; Grygiel, J; Raghavan, D; Sampson, D; Woods, R1

Reviews

16 review(s) available for ribavirin and Neutropenia

ArticleYear
Peginterferon and ribavirin in HCV: improvement of sustained viral response.
    Best practice & research. Clinical gastroenterology, 2008, Volume: 22, Issue:6

    Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Depression; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Medication Adherence; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thrombocytopenia; Treatment Outcome

2008
The role of the community nurse in hepatitis C diagnosis and treatment.
    British journal of community nursing, 2009, Volume: 14, Issue:7

    Topics: Antiviral Agents; Community Health Nursing; Depression; Drug Monitoring; Fatigue; Hepatitis C; Humans; Infection Control; Interferon alpha-2; Interferon-alpha; Neutropenia; Nurse's Role; Nursing Assessment; Patient Education as Topic; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Risk Factors; Social Support; United Kingdom

2009
Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV - the role of epoetin, G-CSF and novel agents.
    Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:9

    Topics: Anemia; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia; Viral Load

2010
Granulocyte colony-stimulating factor for hepatitis C therapy-associated neutropenia: systematic review and economic evaluation.
    Journal of viral hepatitis, 2011, Volume: 18, Issue:7

    Topics: Antiviral Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome

2011
[Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection].
    Orvosi hetilap, 2011, Dec-11, Volume: 152, Issue:50

    Topics: Affect; Anemia, Hypochromic; Antiviral Agents; Autoimmune Diseases; Autoimmunity; Cardiovascular System; Clinical Trials as Topic; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Endocrine System Diseases; Eye; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon-alpha; Neutropenia; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Respiratory System; Ribavirin; Risk Factors; Thrombocytopenia

2011
[Treatment of chronic hepatitis C: side effects, tolerability and quality of life].
    Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2

    Topics: Anemia, Hemolytic; Antiviral Agents; Blood Cell Count; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Liver Transplantation; Mental Disorders; Neutropenia; Prospective Studies; Quality of Life; Retrospective Studies; Ribavirin; Risk Factors; Thrombocytopenia; Time Factors

2002
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia.
    Cleveland Clinic journal of medicine, 2004, Volume: 71 Suppl 3

    Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Darbepoetin alfa; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Filgrastim; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukin-11; Neutropenia; Patient Compliance; Polyethylene Glycols; Quality of Life; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Thrombocytopenia

2004
The role of hematopoietic growth factors in special populations with chronic hepatitis C: patients with HIV coinfection, end-stage renal disease, or liver transplantation.
    Cleveland Clinic journal of medicine, 2004, Volume: 71 Suppl 3

    Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Comorbidity; Drug Therapy, Combination; Erythropoietin; Forecasting; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Kidney Failure, Chronic; Liver Transplantation; Neutropenia; Patient Compliance; Recombinant Proteins; Recurrence; Renal Dialysis; Ribavirin

2004
The role of physician extenders in managing patients with chronic hepatitis C.
    Cleveland Clinic journal of medicine, 2004, Volume: 71 Suppl 3

    Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Neutropenia; Nurse Practitioners; Patient Compliance; Patient Education as Topic; Physician Assistants; Quality of Health Care; Ribavirin; Risk Factors; Social Support; Thrombocytopenia

2004
Hematologic side effects of interferon and ribavirin therapy.
    Journal of clinical gastroenterology, 2005, Volume: 39, Issue:1 Suppl

    Topics: Anemia, Hypochromic; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Erythropoietin; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia

2005
The use of growth factors to manage the hematologic side effects of PEG-interferon alfa and ribavirin.
    Journal of clinical gastroenterology, 2005, Volume: 39, Issue:1 Suppl

    Topics: Anemia, Hypochromic; Antiviral Agents; Darbepoetin alfa; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Granulocyte Colony-Stimulating Factor; Growth Substances; Hematinics; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia

2005
Use of growth factors with antiviral therapy for chronic hepatitis C.
    Clinics in liver disease, 2005, Volume: 9, Issue:3

    Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon Type I; Neutropenia; Patient Compliance; Quality of Life; Recombinant Proteins; Ribavirin; Thrombocytopenia

2005
Management of the hematologic complications of hepatitis C therapy.
    Clinics in liver disease, 2005, Volume: 9, Issue:4

    Topics: Anemia; Antiviral Agents; Bone Marrow; Epoetin Alfa; Erythropoietin; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon Type I; Neutropenia; Recombinant Proteins; Ribavirin; Thrombocytopenia

2005
[Complementary treatments of chronic viral hepatitis C].
    Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:2

    Topics: Anemia; Antidepressive Agents; Antioxidants; Antiviral Agents; Erythropoietin; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia

2006
Use of hematopoietic growth factors as adjuvant therapy for anemia and neutropenia in the treatment of hepatitis C.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:2

    Topics: Anemia; Chemotherapy, Adjuvant; Epoetin Alfa; Erythropoietin; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematinics; Hepatitis C; Humans; Interferons; MEDLINE; Neutropenia; Recombinant Proteins; Ribavirin

2007
Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy.
    Bone marrow transplantation, 1999, Volume: 24, Issue:5

    Topics: Aged; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Incidence; Male; Melphalan; Middle Aged; Multiple Myeloma; Neutropenia; Pilot Projects; Respiratory Syncytial Virus Infections; Ribavirin; Transplantation Conditioning

1999

Trials

20 trial(s) available for ribavirin and Neutropenia

ArticleYear
Sofosbuvir Adverse Events Profile in a Subset of Pakistani Population.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:2

    Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Neutropenia; Pancytopenia; Ribavirin; Sofosbuvir; Thrombocytopenia; Treatment Outcome

2018
A population pharmacodynamic model characterizing neutropenia associated with pegylated interferon alpha 2-a therapy in patients with chronic hepatitis C viral infection.
    Naunyn-Schmiedeberg's archives of pharmacology, 2018, Volume: 391, Issue:9

    Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Models, Biological; Neutropenia; Neutrophils; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2018
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study.
    Antiviral therapy, 2015, Volume: 20, Issue:1

    Topics: Adult; Anemia; Antiviral Agents; Cell Count; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia; Viral Load

2015
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea.
    Clinical and molecular hepatology, 2015, Volume: 21, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Fatigue; Female; Genotype; Headache; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Recurrence; Republic of Korea; Ribavirin; RNA, Viral; Treatment Outcome

2015
Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme.
    The Journal of infection, 2015, Volume: 71, Issue:6

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Bilirubin; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Oligopeptides; Ribavirin; RNA, Viral; Young Adult

2015
Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.
    PloS one, 2016, Volume: 11, Issue:3

    Topics: Adult; Aged; Anemia; Antiviral Agents; Asthenia; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Host-Pathogen Interactions; Humans; Interferon-alpha; Male; Middle Aged; Neutropenia; Outcome Assessment, Health Care; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Ribavirin; RNA, Viral; Withholding Treatment

2016
R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Cytidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Female; Hepacivirus; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Nucleosides; Polyethylene Glycols; Prodrugs; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load

2008
Low weight predicts neutropenia and peginterferon alfa-2a dose reductions during treatment for chronic hepatitis C.
    Journal of viral hepatitis, 2009, Volume: 16, Issue:5

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Body Mass Index; Body Surface Area; Body Weight; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Young Adult

2009
Granulocyte colony stimulating factor in HCV genotype-1 patients who develop Peg-IFN-alpha2b related severe neutropenia: a preliminary report on treatment, safety and efficacy.
    Journal of medical virology, 2009, Volume: 81, Issue:5

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Granulocyte Colony-Stimulating Factor; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Patient Compliance; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Treatment Outcome

2009
Lenograstim in the treatment of severe neutropenia in patients treated with Peg-IFN and ribavirin: the experience of a single hepatology unit.
    Le infezioni in medicina, 2009, Volume: 17, Issue:1

    Topics: Antiviral Agents; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lenograstim; Liver; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2009
[Clinical significance of leukopenia and neutropenia patients with chronic hepatitis "C" in the various regimes antiretroviral therapy].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2010, Issue:5

    Topics: Adult; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Liver Cirrhosis; Male; Middle Aged; Moscow; Neutropenia; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome

2010
The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.
    Gastroenterology, 2011, Volume: 140, Issue:2

    Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome

2011
Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:8

    Topics: Adult; Anemia; Antiviral Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Internationality; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Thrombocytopenia; Treatment Outcome

2012
Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study.
    Journal of hepatology, 2007, Volume: 47, Issue:1

    Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thrombocytopenia; Treatment Outcome

2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3.
    The New England journal of medicine, 2007, Jul-12, Volume: 357, Issue:2

    Topics: Adult; Anemia; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load

2007
IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C.
    Georgian medical news, 2007, Issue:147

    Topics: Adult; Antiviral Agents; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Neutropenia; Recombinant Proteins; Ribavirin

2007
[Toxicity of the treatment of chronic hepatitis C with peginterferon alpha (2a or 2b) plus ribavirin in patients not previously treated].
    Medicina clinica, 2007, Nov-03, Volume: 129, Issue:16

    Topics: Alanine Transaminase; Antiviral Agents; Bilirubin; Cohort Studies; Drug Therapy, Combination; Fatigue; Fever; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Patient Dropouts; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Viral Load

2007
Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.
    Alimentary pharmacology & therapeutics, 2008, Mar-01, Volume: 27, Issue:5

    Topics: Adult; Anemia; Antiviral Agents; Depression; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Surveys and Questionnaires; Thrombocytopenia; Time Factors; Viral Load

2008
A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment.
    Journal of viral hepatitis, 2008, Volume: 15, Issue:5

    Topics: Adult; Anemia; Antiviral Agents; Darbepoetin alfa; Erythropoietin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematinics; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load

2008
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.
    Infection, 2008, Volume: 36, Issue:3

    Topics: Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Incidence; Infections; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome

2008

Other Studies

37 other study(ies) available for ribavirin and Neutropenia

ArticleYear
[Cytopenias and their correction during antiviral therapy of chronic hepatitis C in patients with genotype 1].
    Voprosy virusologii, 2017, Volume: 62, Issue:4

    Topics: Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia; Treatment Outcome

2017
Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 57, Issue:3

    Topics: Adult; Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Middle Aged; Neutropenia; Opportunistic Infections; Prospective Studies; Ribavirin; Risk Assessment

2013
Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2013, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Egypt; Female; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon-alpha; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Ribavirin; Thrombocytopenia; Young Adult

2013
Bone marrow suppression or active proliferation? An analysis of neutropenia after pegylated interferon treatment of patients with chronic hepatitis C.
    Scandinavian journal of infectious diseases, 2013, Volume: 45, Issue:12

    Topics: Adult; Antiviral Agents; Bone Marrow Cells; Cytokines; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Statistics, Nonparametric; Young Adult

2013
Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort.
    Alimentary pharmacology & therapeutics, 2014, Volume: 39, Issue:1

    Topics: Antiviral Agents; Cohort Studies; Comparative Effectiveness Research; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neutropenia; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Ribavirin; Thrombocytopenia; United States; Veterans

2014
Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon-alpha and ribavirin.
    Journal of viral hepatitis, 2014, Volume: 21, Issue:9

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Bacterial Infections; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Retrospective Studies; Ribavirin; Young Adult

2014
Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:7

    Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Epistaxis; Esophageal and Gastric Varices; Feasibility Studies; Female; Gastrointestinal Hemorrhage; Gingival Hemorrhage; Hepatitis C, Chronic; Humans; Infections; Interferon-alpha; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Thrombocytopenia

2014
Simeprevir with peginterferon/ribavirin for treatment of chronic hepatitis C virus genotype 1 infection: pooled safety analysis from Phase IIb and III studies.
    Journal of viral hepatitis, 2015, Volume: 22, Issue:4

    Topics: Anemia; Antiviral Agents; Bilirubin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Exanthema; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Neutropenia; Prevalence; Pruritus; Ribavirin; Simeprevir

2015
Recombinant Human Erythropoietin (RHuEpo) and Granular Colony Stimulating Factor (G-CSF) in hepatitis C virus (HCV) related to mixed cryoglobulinaemia associated to membranoproliferative glomerulonephritis type I: a case report description.
    Le infezioni in medicina, 2014, Volume: 22, Issue:4

    Topics: Anemia; Antiviral Agents; Cryoglobulinemia; Drug Therapy, Combination; Erythropoietin; Glomerulonephritis, Membranoproliferative; Granulocyte Colony-Stimulating Factor; Hepatitis C; Humans; Interferons; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome

2014
Efficacy and safety of pegylated interferon base treatment in patients with chronic hepatitis C on dialysis.
    European journal of internal medicine, 2015, Volume: 26, Issue:4

    Topics: Adult; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kidney Failure, Chronic; Male; Middle Aged; Neutropenia; Patient Dropouts; Polyethylene Glycols; Recombinant Proteins; Renal Dialysis; Republic of Korea; Retrospective Studies; Ribavirin; Treatment Outcome

2015
Safety and Efficacy of Combined Treatment with Pegylated Interferon Alpha-2b and Ribavirin for HCV Genotype 4 in Children.
    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2016, Volume: 36, Issue:1

    Topics: Adolescent; Antiviral Agents; Body Height; Body Weight; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; gamma-Glutamyltransferase; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Neutropenia; Neutrophils; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Surveys and Questionnaires; Treatment Outcome; Viral Load

2016
Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study.
    PloS one, 2016, Volume: 11, Issue:9

    Topics: Adult; Aged; Anemia; Antiviral Agents; Cardiovascular Diseases; Eligibility Determination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Neoplasms; Netherlands; Neutropenia; Patient Selection; Polyethylene Glycols; Recombinant Proteins; Regression Analysis; Retrospective Studies; Ribavirin; Risk Factors

2016
[Haematologic adverse effects of treatment of chronic viral hepatitis B and C].
    Klinicka mikrobiologie a infekcni lekarstvi, 2008, Volume: 14, Issue:2

    Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia

2008
Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice.
    Alimentary pharmacology & therapeutics, 2009, May-01, Volume: 29, Issue:9

    Topics: Adult; Aged; Antiviral Agents; Bacterial Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome; Young Adult

2009
[Case of overwhelming postsplenectomy infection (OPSI) with chronic hepatitis type C during peginterferon/ribavirin combination therapy].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2009, Volume: 106, Issue:3

    Topics: Antiviral Agents; Fatal Outcome; Female; Hepatitis C, Chronic; Humans; Immunocompromised Host; Interferon alpha-2; Interferon-alpha; Middle Aged; Neutropenia; Pneumococcal Infections; Pneumococcal Vaccines; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Ribavirin; Sepsis; Splenectomy

2009
Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Annals of hematology, 2010, Volume: 89, Issue:2

    Topics: Adult; Anemia; Antiviral Agents; Female; Genotype; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Multivariate Analysis; Neutropenia; Ribavirin; Risk Factors; Thrombocytopenia

2010
Reduction in neutrophil count during hepatitis C treatment: drug toxicity or predictor of good response?
    Digestive diseases and sciences, 2010, Volume: 55, Issue:7

    Topics: Adult; Antiviral Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neutropenia; Neutrophils; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Ribavirin; Risk Assessment; RNA, Viral; Statistics, Nonparametric; Treatment Outcome; Viral Load

2010
[Clinical efficacy and safety of the combination therapy of peginterferon alpha and ribavirin in cirrhotic patients with HCV infection].
    The Korean journal of hepatology, 2010, Volume: 16, Issue:1

    Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Severity of Illness Index; Treatment Outcome

2010
Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C.
    Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:4

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Bacterial Infections; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors

2010
Interferon-α suppressed granulocyte colony stimulating factor production is reversed by CL097, a TLR7/8 agonist.
    Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:12

    Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Cells, Cultured; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; Humans; Imidazoles; Interferon alpha-2; Interferon-alpha; Ireland; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols; Prospective Studies; Quinolines; Recombinant Proteins; Ribavirin; Time Factors; Toll-Like Receptor 7; Toll-Like Receptor 8; Treatment Outcome

2010
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
    Journal of hepatology, 2012, Volume: 56, Issue:2

    Topics: Adult; Antiviral Agents; Female; Genome-Wide Association Study; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Linkage Disequilibrium; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Polymorphism, Single Nucleotide; Pyrophosphatases; Recombinant Proteins; Ribavirin; Thrombocytopenia

2012
The study of relationship between neutropenia and infection during treatment with peginterferon α and ribavirin for chronic hepatitis C.
    European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:12

    Topics: Adult; Age Factors; Antiviral Agents; Diabetes Complications; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunocompromised Host; Interferon-alpha; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Opportunistic Infections; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors

2011
Benefits of Reiki therapy for a severely neutropenic patient with associated influences on a true random number generator.
    Journal of alternative and complementary medicine (New York, N.Y.), 2011, Volume: 17, Issue:12

    Topics: Anxiety; Consciousness; Hematocrit; Hepacivirus; Hepatitis C; Humans; Interferons; Leukocyte Count; Male; Middle Aged; Mind-Body Relations, Metaphysical; Neutropenia; Neutrophils; Ribavirin; Severity of Illness Index; Spirituality; Therapeutic Touch

2011
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Anemia; Antiviral Agents; Contraindications; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Practice Guidelines as Topic; Prevalence; Retrospective Studies; Ribavirin; Thrombocytopenia; Young Adult

2012
[A study of the relationship between neutropenia and clinical infection risk during treatment with peginterferon alfa-2a and ribavirin for chronic hepatitis C].
    Zhonghua nei ke za zhi, 2012, Volume: 51, Issue:1

    Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepatitis C, Chronic; Humans; Infections; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors

2012
Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C.
    Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:5

    Topics: Adult; Antiviral Agents; Black People; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Infections; Interferon-alpha; Leukocyte Count; Male; Middle Aged; Neutropenia; Neutrophils; Prevalence; Retrospective Studies; Ribavirin; United States; White People

2002
Role of epoetin alfa in maintaining ribavirin dose.
    Gastroenterology clinics of North America, 2004, Volume: 33, Issue:1 Suppl

    Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Hematinics; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia

2004
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation?
    Antiviral therapy, 2004, Volume: 9, Issue:4

    Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon Type I; Interferon-alpha; Italy; Longitudinal Studies; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Respiratory Tract Infections; Retrospective Studies; Ribavirin

2004
[Severe autoimmune neutropenia and thrombopenia associated with chronic C hepatitis: effect of antiviral therapy].
    Gastroenterologie clinique et biologique, 2005, Volume: 29, Issue:3

    Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Purpura, Thrombocytopenic, Idiopathic; Recombinant Proteins; Ribavirin; RNA, Viral

2005
Incidence and severity of infections according to the development of neutropenia during combined therapy with pegylated interferon-alpha2a plus ribavirin in chronic hepatitis C infection.
    Methods and findings in experimental and clinical pharmacology, 2005, Volume: 27, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Logistic Models; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin

2005
The impact of haematopoietic growth factors on the management and efficacy of antiviral treatment in patients with hepatitis C virus.
    Antiviral therapy, 2005, Volume: 10, Issue:6

    Topics: Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome

2005
Parotitis associated with a parainfluenza virus type 3 infection during aplasia after unrelated allogeneic stem cell transplantation.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:8

    Topics: Adult; Hematopoietic Stem Cell Transplantation; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Neutropenia; Parainfluenza Virus 3, Human; Parotitis; Respirovirus Infections; Ribavirin; Transplantation, Homologous

2006
Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2006, Volume: 20, Issue:9

    Topics: Adult; Age Factors; Aged; Anemia; Antiviral Agents; Biomarkers; Blood Cell Count; Blood Platelets; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols; Quebec; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Thrombocytopenia; Treatment Outcome

2006
Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HCV therapy.
    Journal of viral hepatitis, 2007, Volume: 14, Issue:11

    Topics: Antiviral Agents; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Logistic Models; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Time Factors; Treatment Outcome

2007
Multiple, repeated filgrastim treatment cycles to recover severe, recurring pegylated interferon-related neutropenia.
    Hepato-gastroenterology, 2007, Volume: 54, Issue:78

    Topics: Adult; Antiviral Agents; Filgrastim; Genotype; Granulocyte Colony-Stimulating Factor; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Recurrence; Ribavirin; Treatment Outcome

2007
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients.
    Antiviral therapy, 2007, Volume: 12, Issue:8

    Topics: Adult; Anemia; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Fibrosis; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Neutropenia; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Spain; Thrombocytopenia; Zidovudine

2007
Phase I and pharmacokinetic study of tiazofurin (NSC 286193) administered by 5-day continuous infusion.
    Cancer chemotherapy and pharmacology, 1986, Volume: 16, Issue:2

    Topics: Adult; Chromatography, High Pressure Liquid; Conjunctivitis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Humans; Kinetics; Male; Middle Aged; Neoplasms; Neutropenia; Ribavirin; Ribonucleosides

1986